/
Stock
/
/
APIChangelogInfo

FULCRUM THERAPEUTICS

Trade FULC
FULC Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-05-08
2025-05-09
TOURANGEAU GREG
Principal Accounting Officer
S - Sale
Common Stock
-498
$5.00
-2,490
1
$365.98M
2025-01-24
2025-01-28
SAPIR ALEX
President & Chief Executive Of...
A - Grant
Stock option - Right to Buy
582K
$0.00
1
$365.98M
2025-01-24
2025-01-28
TOURANGEAU GREG
Principal Accounting Officer
A - Grant
Stock Option (right to buy)
76,120
$0.00
1
$365.98M
2025-01-24
2025-01-28
OLTMANS CURTIS GALE
Chief Legal Officer
A - Grant
Stock Option (right to buy)
225K
$0.00
1
$365.98M
2025-01-24
2025-01-28
MUSSO ALAN
Chief Financial Officer
A - Grant
Stock Option (right to buy)
285K
$0.00
1
$365.98M
2024-11-12
2024-11-14
KING RACHEL
A - Grant
Stock Option (right to buy)
60,000
$0.00
1
$365.98M
2024-08-21
2024-08-23
RA CAPITAL MANAGEMENT, L.P.
J - Other
Common Stock
-8.50M
1
$365.98M
2024-08-21
2024-08-23
RA CAPITAL MANAGEMENT, L.P.
J - Other
Warrant (Right to Buy)
8.50M
1
$365.98M
2024-07-03
2024-07-08
SAPIR ALEX
President & Chief Executive Of...
M - Exercise
Stock option - Right to Buy
-150K
$0.00
1
$365.98M
2024-07-03
2024-07-08
SAPIR ALEX
President & Chief Executive Of...
M - Exercise
Common Stock
150K
$3.00
450K
1
$365.98M
2024-06-17
2024-06-18
DORTON KATINA
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$365.98M
2024-06-17
2024-06-18
BANKS SONJA
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$365.98M
2024-06-17
2024-06-18
COLLINS JAMES
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$365.98M
2024-06-17
2024-06-18
EZEKOWITZ ALAN
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$365.98M
2024-06-17
2024-06-18
GERAGHTY JAMES
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$365.98M
2024-06-17
2024-06-18
GOULD ROBERT
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$365.98M
2024-06-17
2024-06-18
HAVILAND KATE
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$365.98M
2024-06-17
2024-06-18
HILL COLIN
A - Grant
Stock Option (right to buy)
60,000
$0.00
1
$365.98M
2024-05-07
2024-05-09
TOURANGEAU GREG
Principal Accounting Officer
S - Sale
Common Stock
-236
$8.00
-1,888
1
$365.98M
2024-03-18
2024-03-20
HORN PATRICK TAYLOR
Chief Medical Officer
A - Grant
Stock Option (right to buy)
400K
$0.00
1
$365.98M
2024-03-08
2024-03-08
TOURANGEAU GREG
Vice President, Finance
S - Sale
Common Stock
-4,884
$12.00
-58,608
1
$365.98M
2024-03-04
2024-03-05
SAPIR ALEX
President & Chief Executive Of...
P - Purchase
Common Stock
43,360
$11.00
477K
1
$365.98M
2024-01-26
2024-01-30
MUSSO ALAN
Chief Financial Officer
A - Grant
Stock Option (right to buy)
100K
$0.00
1
$365.98M
2024-01-26
2024-01-30
OLTMANS CURTIS GALE
Chief Legal Officer
A - Grant
Stock Option (right to buy)
150K
$0.00
1
$365.98M
2024-01-26
2024-01-30
TOURANGEAU GREG
Vice President, Finance
A - Grant
Stock Option (right to buy)
93,820
$0.00
2
$365.98M
2024-01-17
2024-01-19
MUSSO ALAN
Chief Financial Officer
A - Grant
Stock Option (right to buy)
61,822
$0.00
1
$365.98M
2023-08-07
2023-08-09
MUSSO ALAN
Chief Financial Officer
A - Grant
Stock Option (right to buy)
433K
$0.00
1
$365.98M
2023-06-27
2023-06-29
COLLINS JAMES
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$365.98M
2023-06-27
2023-06-29
DORTON KATINA
A - Grant
Stock Option (Right to Buy)
30,000
$0.00
1
$365.98M
2023-06-27
2023-06-29
EZEKOWITZ ALAN
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$365.98M
2023-06-27
2023-06-29
GERAGHTY JAMES
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$365.98M
2023-06-27
2023-06-29
GOULD ROBERT
Interim President & CEO
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$365.98M
2023-06-27
2023-06-29
HAVILAND KATE
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$365.98M
2023-06-27
2023-06-29
BANKS SONJA
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$365.98M
2023-05-10
2023-05-11
TOURANGEAU GREG
Principal Accounting Officer
S - Sale
Common Stock
-210
$3.00
-630
1
$365.98M
2023-04-26
2023-04-28
HAYES MELVIN III
Chief Operating Officer
A - Grant
Stock Option (right to buy)
115K
$0.00
1
$365.98M
2023-04-26
2023-04-28
OLTMANS CURTIS GALE
Chief Legal Officer
A - Grant
Stock Option (right to buy)
128K
$0.00
1
$365.98M
2023-02-09
2023-02-13
OLTMANS CURTIS GALE
Chief Legal Officer
A - Grant
Stock Option (right to buy)
150K
$0.00
1
$365.98M
2023-02-09
2023-02-13
HAYES MELVIN III
Chief Operating Officer
A - Grant
Stock Option (right to buy)
135K
$0.00
1
$365.98M
2023-02-09
2023-02-13
RAJAVELU ESTHER
Chief Financial Officer
A - Grant
Stock Option (right to buy)
160K
$0.00
1
$365.98M
2023-02-09
2023-02-13
TOURANGEAU GREG
Controller
A - Grant
Stock Option (right to buy)
16,100
$0.00
1
$365.98M
2023-01-20
2023-01-24
RA CAPITAL MANAGEMENT, L.P.
P - Purchase
Common Stock
1.92M
$13.00
25M
1
$365.98M
2023-01-13
2023-01-13
GOULD ROBERT
Interim President & CEO
S - Sale
Common Stock
-6,766
$15.00
-101K
1
$365.98M
2023-01-04
2023-01-06
RA CAPITAL MANAGEMENT, L.P.
P - Purchase
Common Stock
181K
$7.00
1.26M
2
$365.98M
2022-12-27
2022-12-29
RA CAPITAL MANAGEMENT, L.P.
P - Purchase
Common Stock
4,089
$6.00
24,534
1
$365.98M
2022-12-19
2022-12-21
RA CAPITAL MANAGEMENT, L.P.
P - Purchase
Common Stock
98,787
$6.00
593K
1
$365.98M
2022-12-16
2022-12-16
RA CAPITAL MANAGEMENT, L.P.
P - Purchase
Common Stock
1.34M
$5.00
6.71M
1
$365.98M
2022-12-15
2022-12-16
RA CAPITAL MANAGEMENT, L.P.
P - Purchase
Common Stock
237K
$5.00
1.19M
1
$365.98M
2022-12-14
2022-12-16
RA CAPITAL MANAGEMENT, L.P.
P - Purchase
Common Stock
825K
$5.00
4.12M
1
$365.98M
2022-12-13
2022-12-15
THIRD ROCK VENTURES III, L.P.
J - Other
Common Stock
-2.00M
1
$365.98M
2022-11-07
2022-11-09
ARROYO SANTIAGO
Chief Medical Officer
A - Grant
Stock Option (right to buy)
400K
$0.00
1
$365.98M
2022-08-09
2022-08-11
HAYES MELVIN III
Chief Operating Officer
A - Grant
Stock Option (right to buy)
137K
$0.00
1
$365.98M
2022-08-09
2022-08-11
OLTMANS CURTIS GALE
Chief Legal Officer
A - Grant
Stock Option (right to buy)
50,000
$0.00
1
$365.98M
2022-07-15
2022-07-19
TOURANGEAU GREG
Controller
A - Grant
Stock Option (right to buy)
16,540
$0.00
1
$365.98M
2022-06-28
2022-06-29
EZEKOWITZ ALAN
J - Other
Stock Option (right to buy)
-500
$0.00
1
$365.98M
2022-06-27
2022-06-29
DORTON KATINA
A - Grant
Stock Option (right to buy)
19,000
$0.00
1
$365.98M
2022-06-27
2022-06-29
COLLINS JAMES
A - Grant
Stock Option (right to buy)
19,000
$0.00
1
$365.98M
2022-06-27
2022-06-29
GERAGHTY JAMES
A - Grant
Stock Option (right to buy)
19,000
$0.00
1
$365.98M
2022-06-27
2022-06-29
GOULD ROBERT
A - Grant
Stock Option (right to buy)
19,000
$0.00
1
$365.98M
2022-06-27
2022-06-29
HAVILAND KATE
A - Grant
Stock Option (right to buy)
19,000
$0.00
1
$365.98M
2022-06-27
2022-06-29
EZEKOWITZ ALAN
A - Grant
Stock Option (right to buy)
19,000
$0.00
1
$365.98M
2022-06-27
2022-06-29
BANKS SONJA
A - Grant
Stock Option (right to buy)
19,000
$0.00
1
$365.98M
2022-06-07
2022-06-08
GOULD ROBERT
M - Exercise
Common Stock
71,435
$8.00
571K
1
$365.98M
2022-06-07
2022-06-08
GOULD ROBERT
S - Sale
Common Stock
-71,435
$8.00
-571K
1
$365.98M
2022-06-07
2022-06-08
GOULD ROBERT
M - Exercise
Stock Option (right to buy)
-71,435
$0.00
1
$365.98M
2022-06-06
2022-06-06
GOULD ROBERT
M - Exercise
Common Stock
24,382
$8.00
195K
1
$365.98M
2022-06-06
2022-06-06
GOULD ROBERT
M - Exercise
Stock Option (right to buy)
-24,382
$0.00
1
$365.98M
2022-06-06
2022-06-06
GOULD ROBERT
S - Sale
Common Stock
-24,382
$8.00
-195K
1
$365.98M
2022-06-03
2022-06-06
GOULD ROBERT
M - Exercise
Stock Option (right to buy)
-25,551
$0.00
1
$365.98M
2022-06-03
2022-06-06
GOULD ROBERT
M - Exercise
Common Stock
25,551
$8.00
204K
1
$365.98M
2022-06-03
2022-06-06
GOULD ROBERT
S - Sale
Common Stock
-25,551
$8.00
-204K
1
$365.98M
2022-06-02
2022-06-06
GOULD ROBERT
M - Exercise
Stock Option (right to buy)
-16,689
$0.00
1
$365.98M
2022-06-02
2022-06-06
GOULD ROBERT
M - Exercise
Common Stock
16,689
$8.00
134K
1
$365.98M
2022-06-02
2022-06-06
GOULD ROBERT
S - Sale
Common Stock
-16,689
$8.00
-134K
1
$365.98M
2022-05-06
2022-05-10
TOURANGEAU GREG
Controller
A - Grant
Stock Option (right to buy)
6,500
$0.00
1
$365.98M
2022-05-06
2022-05-10
TOURANGEAU GREG
Controller
A - Grant
Common Stock
3,250
$0.00
1
$365.98M
2022-04-07
2022-04-11
GOULD ROBERT
M - Exercise
Stock Option (right to buy)
-5,631
$0.00
1
$365.98M
2022-04-07
2022-04-11
GOULD ROBERT
M - Exercise
Common Stock
5,631
$8.00
45,048
1
$365.98M
2022-04-07
2022-04-11
GOULD ROBERT
S - Sale
Common Stock
-5,631
$24.00
-135K
1
$365.98M
2022-04-05
2022-04-05
GOULD ROBERT
M - Exercise
Stock Option (right to buy)
-52,552
$0.00
1
$365.98M
2022-04-05
2022-04-05
GOULD ROBERT
S - Sale
Common Stock
-52,552
$24.00
-1.26M
1
$365.98M
2022-04-05
2022-04-05
GOULD ROBERT
M - Exercise
Common Stock
52,552
$8.00
420K
1
$365.98M
2022-04-04
2022-04-05
GOULD ROBERT
S - Sale
Common Stock
-7,235
$24.00
-174K
1
$365.98M
2022-04-04
2022-04-05
GOULD ROBERT
M - Exercise
Stock Option (right to buy)
-7,235
$0.00
1
$365.98M
2022-04-04
2022-04-05
GOULD ROBERT
M - Exercise
Common Stock
7,235
$8.00
57,880
1
$365.98M
2022-04-01
2022-04-05
GOULD ROBERT
M - Exercise
Stock Option (right to buy)
-34,464
$0.00
1
$365.98M
2022-04-01
2022-04-05
GOULD ROBERT
M - Exercise
Common Stock
34,464
$8.00
276K
1
$365.98M
2022-04-01
2022-04-05
GOULD ROBERT
S - Sale
Common Stock
-34,464
$24.00
-827K
1
$365.98M
2022-01-19
2022-01-21
STUART BRYAN
President & Chief Executive Of...
A - Grant
Stock Option (right to buy)
340K
$0.00
1
$365.98M
2022-01-19
2022-01-21
DUNN JUDITH
President, Research & Developm...
A - Grant
Stock Option (right to buy)
141K
$0.00
1
$365.98M
2022-01-19
2022-01-21
MORABITO CHRISTOPHER
Chief Medical Officer
A - Grant
Stock Option (right to buy)
59,744
$0.00
1
$365.98M
2022-01-19
2022-01-21
OLTMANS CURTIS GALE
SVP, General Counsel
A - Grant
Stock Option (right to buy)
60,000
$0.00
1
$365.98M
2022-01-19
2022-01-21
THOMSON PETER
VP Finance & Accounting
A - Grant
Stock Option (right to buy)
40,000
$0.00
1
$365.98M
2022-01-03
2022-01-10
RAJAVELU ESTHER
Chief Financial Officer
A - Grant
Stock Option (right to buy)
200K
$0.00
1
$365.98M
2021-12-17
2022-01-07
OLTMANS CURTIS GALE
SVP, General Counsel
G - Gift
Common Stock
-1,088
$0.00
1
$365.98M
2021-12-08
2021-12-09
BANKS SONJA
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$365.98M
2021-11-10
2021-11-12
LEVIN MARK
J - Other
Common Stock
-1.00M
1
$365.98M
2021-11-10
2021-11-12
THIRD ROCK VENTURES III, L.P.
J - Other
Common Stock
-1.00M
1
$365.98M
2021-09-22
2021-09-24
LEVIN MARK
J - Other
Common Stock
-1.00M
1
$365.98M
2021-09-22
2021-09-24
THIRD ROCK VENTURES III, L.P.
J - Other
Common Stock
-1.00M
1
$365.98M
2021-08-11
2021-08-12
STUART BRYAN
President & Chief Executive Of...
S - Sale
Common Stock
-28,000
$24.00
-672K
1
$365.98M
2021-08-11
2021-08-12
STUART BRYAN
President & Chief Executive Of...
M - Exercise
Common Stock
28,000
$8.00
224K
1
$365.98M
2021-08-11
2021-08-12
STUART BRYAN
President & Chief Executive Of...
M - Exercise
Stock Option (right to buy)
-28,000
$0.00
1
$365.98M
2021-08-10
2021-08-12
STUART BRYAN
President & Chief Executive Of...
M - Exercise
Stock Option (right to buy)
-32,000
$0.00
1
$365.98M
2021-08-10
2021-08-12
MOXHAM CHRISTOPHER
Chief Scientific Officer
S - Sale
Common Stock
-20,714
$17.00
-352K
1
$365.98M
2021-08-10
2021-08-12
MOXHAM CHRISTOPHER
Chief Scientific Officer
S - Sale
Common Stockm
-31,071
$18.00
-559K
1
$365.98M
2021-08-10
2021-08-12
STUART BRYAN
President & Chief Executive Of...
S - Sale
Common Stock
-32,000
$18.00
-576K
1
$365.98M
2021-08-10
2021-08-12
MOXHAM CHRISTOPHER
Chief Scientific Officer
M - Exercise
Stock Option (right to buy)
-51,785
$0.00
2
$365.98M
2021-08-10
2021-08-12
MOXHAM CHRISTOPHER
Chief Scientific Officer
M - Exercise
Common Stock
51,785
$8.00
414K
2
$365.98M
2021-08-10
2021-08-12
STUART BRYAN
President & Chief Executive Of...
M - Exercise
Common Stock
32,000
$8.00
256K
1
$365.98M
2021-06-28
2021-06-29
THOMSON PETER
VP Finance & Accounting
P - Purchase
Common Stock
2,300
$9.00
20,700
1
$365.98M
2021-06-28
2021-06-29
GERAGHTY JAMES
P - Purchase
Common Stock
10,000
$9.00
90,000
1
$365.98M
2021-06-28
2021-06-29
OLTMANS CURTIS GALE
SVP, General Counsel
P - Purchase
Common Stock
1,088
$9.00
9,792
1
$365.98M
2021-06-28
2021-06-29
MORABITO CHRISTOPHER
Chief Medical Officer
P - Purchase
Common Stock
1,100
$9.00
9,900
1
$365.98M
2021-06-09
2021-06-11
HAVILAND KATE
A - Grant
Stock Option (right to buy)
15,000
$0.00
1
$365.98M
2021-06-09
2021-06-11
LEVIN MARK
A - Grant
Stock Option (right to buy)
15,000
$0.00
1
$365.98M
2021-06-09
2021-06-11
GERAGHTY JAMES
A - Grant
Stock Option (right to buy)
15,000
$0.00
1
$365.98M
2021-06-09
2021-06-11
COLLINS JAMES
A - Grant
Stock Option (right to buy)
15,000
$0.00
1
$365.98M
2021-06-09
2021-06-11
DORTON KATINA
A - Grant
Stock Option (right to buy)
15,000
$0.00
1
$365.98M
2021-06-09
2021-06-11
EZEKOWITZ ALAN
A - Grant
Stock Option (right to buy)
15,000
$0.00
1
$365.98M
2021-05-10
2021-05-12
MORABITO CHRISTOPHER
Chief Medical Officer
A - Grant
Stock Option (right to buy)
163K
$0.00
1
$365.98M
2021-04-01
2021-04-02
DUNN JUDITH
President, Research & Developm...
A - Grant
Stock Option (right to buy)
215K
$0.00
1
$365.98M
2021-03-31
2021-04-02
STUART BRYAN
President & Chief Executive Of...
A - Grant
Stock Option (right to buy)
350K
$0.00
1
$365.98M
2021-03-16
2021-03-17
GOULD ROBERT
President & Chief Executive Of...
S - Sale
Common Stock
-789
$12.00
-9,468
1
$365.98M
2021-03-15
2021-03-17
GOULD ROBERT
President & Chief Executive Of...
S - Sale
Common Stock
-9,211
$12.00
-111K
1
$365.98M
2021-02-22
2021-02-24
THOMSON PETER
VP Finance & Accounting
S - Sale
Common Stock
-5,000
$15.00
-75,000
1
$365.98M
2021-02-22
2021-02-24
THOMSON PETER
VP Finance & Accounting
M - Exercise
Stock Option (right to buy)
-5,000
$0.00
1
$365.98M
2021-02-22
2021-02-24
THOMSON PETER
VP Finance & Accounting
M - Exercise
Common Stock
5,000
$8.00
40,000
1
$365.98M
2021-02-16
2021-02-18
GOULD ROBERT
President & Chief Executive Of...
S - Sale
Common Stock
-8,215
$14.00
-115K
2
$365.98M
2021-02-08
2021-02-10
MOXHAM CHRISTOPHER
Chief Scientific Officer
A - Grant
Stock Option (right to buy)
100K
$0.00
1
$365.98M
2021-02-02
2021-02-04
GOULD ROBERT
President & Chief Executive Of...
A - Grant
Stock Option (right to buy)
269K
$0.00
1
$365.98M
2021-01-25
2021-01-27
STUART BRYAN
Chief Operating Officer
A - Grant
Stock Option (right to buy)
134K
$0.00
1
$365.98M
2021-01-25
2021-01-27
THOMSON PETER
VP Finance & Accounting
A - Grant
Stock Option (right to buy)
40,000
$0.00
1
$365.98M
2021-01-21
2021-01-25
THOMSON PETER
VP Finance & Accounting
S - Sale
Common Stock
-6,607
$14.00
-92,498
1
$365.98M
2021-01-20
2021-01-22
GOULD ROBERT
President & Chief Executive Of...
S - Sale
Common Stock
-10,000
$12.00
-120K
1
$365.98M
2020-12-03
2020-12-07
EZEKOWITZ ALAN
A - Grant
Stock Option (right to buy)
15,000
$0.00
1
$365.98M
2020-12-03
2020-12-07
OLTMANS CURTIS GALE
SVP, General Counsel
A - Grant
Stock Option (right to buy)
154K
$0.00
1
$365.98M
2020-09-14
2020-09-14
WALLACE OWEN
Chief Scientific Officer
M - Exercise
Stock Option (right to buy)
-6,350
$0.00
1
$365.98M
2020-09-14
2020-09-14
WALLACE OWEN
Chief Scientific Officer
M - Exercise
Common Stock
6,350
$8.00
50,800
1
$365.98M
2020-07-08
2020-07-09
GOULD ROBERT
President & Chief Executive Of...
S - Sale
Common Stock
-2,500
$20.00
-50,000
1
$365.98M
2020-07-08
2020-07-09
WALLACE OWEN
Chief Scientific Officer
S - Sale
Common Stock
-2,951
$20.00
-59,020
1
$365.98M
2020-07-08
2020-07-09
WALLACE OWEN
Chief Scientific Officer
M - Exercise
Stock Option (right to buy)
-2,951
$0.00
1
$365.98M
2020-07-08
2020-07-09
WALLACE OWEN
Chief Scientific Officer
M - Exercise
Common Stock
2,951
$8.00
23,608
1
$365.98M
2020-07-01
2020-07-02
CADAVID DIEGO
SVP Clinical Development
S - Sale
Common Stock
-1,071
$18.00
-19,278
1
$365.98M
2020-06-30
2020-07-01
WALLACE OWEN
Chief Scientific Officer
M - Exercise
Stock Option (right to buy)
-141
$0.00
1
$365.98M
2020-06-30
2020-07-01
WALLACE OWEN
Chief Scientific Officer
M - Exercise
Common Stock
141
$8.00
1,128
1
$365.98M
2020-06-30
2020-07-01
WALLACE OWEN
Chief Scientific Officer
S - Sale
Common Stock
-141
$20.00
-2,820
1
$365.98M
2020-06-25
2020-06-26
CADAVID DIEGO
SVP Clinical Development
S - Sale
Common Stock
-1,459
$22.00
-32,098
1
$365.98M
2020-06-25
2020-06-26
GOULD ROBERT
President & Chief Executive Of...
S - Sale
Common Stock
-2,500
$21.00
-52,500
1
$365.98M
2020-06-25
2020-06-26
CADAVID DIEGO
SVP Clinical Development
M - Exercise
Stock Option (right to buy)
-1,459
$0.00
1
$365.98M
2020-06-25
2020-06-26
CADAVID DIEGO
SVP Clinical Development
M - Exercise
Common Stock
1,459
$5.00
7,295
1
$365.98M
2020-06-11
2020-06-15
COLLINS JAMES
A - Grant
Stock Option (right to buy)
9,285
$0.00
1
$365.98M
2020-06-11
2020-06-15
EZEKOWITZ ALAN
A - Grant
Stock Option (right to buy)
9,285
$0.00
1
$365.98M
2020-06-11
2020-06-15
GERAGHTY JAMES
A - Grant
Stock Option (right to buy)
9,285
$0.00
1
$365.98M
2020-06-11
2020-06-15
HAVILAND KATE
A - Grant
Stock Option (right to buy)
9,285
$0.00
1
$365.98M
2020-06-11
2020-06-15
LEVIN MARK
A - Grant
Stock Option (right to buy)
9,285
$0.00
1
$365.98M
2020-06-10
2020-06-12
CADAVID DIEGO
SVP Clinical Development
M - Exercise
Stock Option (right to buy)
-401
$0.00
1
$365.98M
2020-06-10
2020-06-12
CADAVID DIEGO
SVP Clinical Development
S - Sale
Common Stock
-401
$22.00
-8,822
1
$365.98M
2020-06-10
2020-06-12
CADAVID DIEGO
SVP Clinical Development
M - Exercise
Common Stock
401
$5.00
2,005
1
$365.98M
2020-06-09
2020-06-10
GOULD ROBERT
President & Chief Executive Of...
S - Sale
Common Stock
-156
$20.00
-3,120
1
$365.98M
2020-06-05
2020-06-09
GOULD ROBERT
President & Chief Executive Of...
S - Sale
Common Stock
-3,433
$20.00
-68,660
1
$365.98M
2020-06-05
2020-06-08
CADAVID DIEGO
SVP Clinical Development
S - Sale
Common Stock
-451
$20.00
-9,020
1
$365.98M
2020-06-05
2020-06-08
CADAVID DIEGO
SVP Clinical Development
M - Exercise
Common Stock
451
$5.00
2,255
1
$365.98M
2020-06-05
2020-06-08
CADAVID DIEGO
SVP Clinical Development
M - Exercise
Stock Option (right to buy)
-451
$0.00
1
$365.98M
2020-06-04
2020-06-08
CADAVID DIEGO
SVP Clinical Development
M - Exercise
Stock Option (right to buy)
-226
$0.00
1
$365.98M
2020-06-04
2020-06-08
CADAVID DIEGO
SVP Clinical Development
M - Exercise
Common Stock
226
$5.00
1,130
1
$365.98M
2020-06-04
2020-06-08
CADAVID DIEGO
SVP Clinical Development
S - Sale
Common Stock
-226
$20.00
-4,520
1
$365.98M
2020-06-04
2020-06-05
GOULD ROBERT
President & Chief Executive Of...
S - Sale
Common Stock
-1,300
$20.00
-26,000
1
$365.98M
2020-06-03
2020-06-05
GOULD ROBERT
President & Chief Executive Of...
S - Sale
Common Stock
-1,500
$20.00
-30,000
1
$365.98M
2020-06-03
2020-06-04
CADAVID DIEGO
SVP Clinical Development
M - Exercise
Common Stock
338
$5.00
1,690
1
$365.98M
2020-06-03
2020-06-04
CADAVID DIEGO
SVP Clinical Development
S - Sale
Common Stock
-338
$20.00
-6,760
1
$365.98M
2020-06-03
2020-06-04
CADAVID DIEGO
SVP Clinical Development
M - Exercise
Stock Option (right to buy)
-338
$0.00
1
$365.98M
2020-06-02
2020-06-04
CADAVID DIEGO
SVP Clinical Development
S - Sale
Common Stock
-45
$20.00
-900
1
$365.98M
2020-06-02
2020-06-04
CADAVID DIEGO
SVP Clinical Development
M - Exercise
Stock Option (right to buy)
-45
$0.00
1
$365.98M
2020-06-02
2020-06-04
CADAVID DIEGO
SVP Clinical Development
M - Exercise
Common Stock
45
$5.00
225
1
$365.98M
2020-06-02
2020-06-03
GOULD ROBERT
President & Chief Executive Of...
S - Sale
Common Stock
-2,797
$20.00
-55,940
1
$365.98M
2020-06-01
2020-06-03
GOULD ROBERT
President & Chief Executive Of...
S - Sale
Common Stock
-5
$20.00
-100
1
$365.98M
2020-05-29
2020-06-01
GOULD ROBERT
President & Chief Executive Of...
S - Sale
Common Stock
-1,390
$20.00
-27,800
1
$365.98M
2020-05-29
2020-06-01
CADAVID DIEGO
SVP Clinical Development
S - Sale
Common Stock
-200
$20.00
-4,000
1
$365.98M
2020-05-29
2020-06-01
CADAVID DIEGO
SVP Clinical Development
M - Exercise
Stock Option (right to buy)
-200
$0.00
1
$365.98M
2020-05-29
2020-06-01
CADAVID DIEGO
SVP Clinical Development
M - Exercise
Common Stock
200
$5.00
1,000
1
$365.98M
2020-05-28
2020-06-01
GOULD ROBERT
President & Chief Executive Of...
S - Sale
Common Stock
-1,919
$20.00
-38,380
1
$365.98M
2020-05-28
2020-06-01
WALLACE OWEN
Chief Scientific Officer
S - Sale
Common Stock
-2,232
$20.00
-44,640
1
$365.98M
2020-05-28
2020-06-01
CADAVID DIEGO
SVP Clinical Development
M - Exercise
Common Stock
600
$5.00
3,000
1
$365.98M
2020-05-28
2020-06-01
WALLACE OWEN
Chief Scientific Officer
M - Exercise
Stock Option (right to buy)
-2,232
$0.00
1
$365.98M
2020-05-28
2020-06-01
WALLACE OWEN
Chief Scientific Officer
M - Exercise
Common Stock
2,232
$8.00
17,856
1
$365.98M
2020-05-28
2020-06-01
CADAVID DIEGO
SVP Clinical Development
M - Exercise
Stock Option (right to buy)
-600
$0.00
1
$365.98M
2020-05-28
2020-06-01
CADAVID DIEGO
SVP Clinical Development
S - Sale
Common Stock
-600
$20.00
-12,000
1
$365.98M
2020-05-27
2020-05-29
WALLACE OWEN
Chief Scientific Officer
M - Exercise
Common Stock
448
$8.00
3,584
1
$365.98M
2020-05-27
2020-05-29
WALLACE OWEN
Chief Scientific Officer
S - Sale
Common Stock
-448
$20.00
-8,960
1
$365.98M
2020-05-27
2020-05-29
WALLACE OWEN
Chief Scientific Officer
M - Exercise
Stock Option (right to buy)
-448
$0.00
1
$365.98M
2020-05-26
2020-05-28
WALLACE OWEN
Chief Scientific Officer
S - Sale
Common Stock
-412
$20.00
-8,240
1
$365.98M
2020-05-26
2020-05-28
GOULD ROBERT
President & Chief Executive Of...
S - Sale
Common Stock
-2,500
$20.00
-50,000
1
$365.98M
2020-05-26
2020-05-28
WALLACE OWEN
Chief Scientific Officer
M - Exercise
Stock Option (right to buy)
-412
$0.00
1
$365.98M
2020-05-26
2020-05-28
WALLACE OWEN
Chief Scientific Officer
M - Exercise
Common Stock
412
$8.00
3,296
1
$365.98M
2020-05-12
2020-05-12
CADAVID DIEGO
SVP Clinical Development
S - Sale
Common Stock
-1,860
$18.00
-33,480
1
$365.98M
2020-05-12
2020-05-12
CADAVID DIEGO
SVP Clinical Development
M - Exercise
Stock Option (right to buy)
-1,860
$0.00
1
$365.98M
2020-05-12
2020-05-12
CADAVID DIEGO
SVP Clinical Development
M - Exercise
Common Stock
1,860
$5.00
9,300
1
$365.98M
2020-05-11
2020-05-12
THOMSON PETER
VP Finance & Accounting
S - Sale
Common Stock
-7,500
$16.00
-120K
1
$365.98M
2020-03-02
2020-03-02
CADAVID DIEGO
SVP Clinical Development
S - Sale
Common Stock
-2,143
$17.00
-36,431
2
$365.98M
2020-02-24
2020-02-26
THOMSON PETER
VP Finance & Accounting
S - Sale
Common Stock
-5,000
$17.00
-85,000
3
$365.98M
2020-02-19
2020-02-20
WALLACE OWEN
Chief Scientific Officer
M - Exercise
Common Stock
6,088
$8.00
48,704
1
$365.98M
2020-02-19
2020-02-20
WALLACE OWEN
Chief Scientific Officer
M - Exercise
Stock Option (right to buy)
-6,088
$0.00
1
$365.98M
2020-02-19
2020-02-20
GOULD ROBERT
President & Chief Executive Of...
S - Sale
Common Stock
-2,500
$20.00
-50,000
1
$365.98M
2020-02-19
2020-02-20
WALLACE OWEN
Chief Scientific Officer
S - Sale
Common Stock
-6,088
$20.00
-122K
1
$365.98M
2020-02-03
2020-02-05
CADAVID DIEGO
SVP Clinical Development
S - Sale
Common Stock
-2,143
$17.00
-36,431
1
$365.98M
2020-01-23
2020-01-27
GOULD ROBERT
President & CEO
A - Grant
Stock Option (right to buy)
200K
$0.00
1
$365.98M
2020-01-23
2020-01-27
STUART BRYAN
Chief Operating Officer
A - Grant
Stock Option (right to buy)
105K
$0.00
1
$365.98M
2020-01-23
2020-01-27
THOMSON PETER
VP Finance & Accounting
A - Grant
Stock Option (right to buy)
33,100
$0.00
1
$365.98M
2020-01-23
2020-01-27
WALLACE OWEN
Chief Scientific Officer
A - Grant
Stock Option (right to buy)
58,900
$0.00
1
$365.98M
2020-01-23
2020-01-27
THOMSON PETER
VP Finance & Accounting
S - Sale
Common Stock
-5,000
$17.00
-85,000
2
$365.98M
2020-01-23
2020-01-27
CADAVID DIEGO
SVP Clinical Development
A - Grant
Stock Option (right to buy)
55,440
$0.00
1
$365.98M
2020-01-02
2020-01-06
DORTON KATINA
A - Grant
Stock Option (right to buy)
18,571
$0.00
1
$365.98M